Chronic viral coinfections differentially affect the likelihood of developing long COVID

Chronic viral coinfections differentially affect the likelihood of developing long COVID

BACKGROUND. The presence and reactivation of chronic viral infections, such as EBV, CMV, and HIV, have been proposed as potential contributors to long COVID (LC), but studies in well-characterized postacute cohorts of individuals with COVID-19 over a longer time course consistent with current case d...

Shranjeno v:

Bibliografske podrobnosti
Main Authors:	Michael J. Peluso, Tyler‐Marie Deveau, Sadie E. Munter, Dylan Ryder, Amanda M. Buck, Gabriele Beck‐Engeser, Fay Chan, Scott Lu, Sarah A. Goldberg, Rebecca Hoh, Viva Tai, Leonel Torres, Nikita S. Iyer, Monika Deswal, Lynn H. Ngo, Melissa Buitrago, Antonio Rodríguez, Jessica Y. Chen, Brandon C. Yee, Ahmed Chenna, John Winslow, Christos J. Petropoulos, Amelia N. Deitchman, Joanna Hellmuth, Matthew A. Spinelli, Matthew S. Durstenfeld, Priscilla Y. Hsue, J. Daniel Kelly, Jeffrey N. Martin, Steven G. Deeks, Peter W. Hunt, Timothy J. Henrich
Format:	Artigo
Jezik:	angleščina
Izdano:	2022
Online dostop:	https://doi.org/10.1172/jci163669 http://www.jci.org/articles/view/163669/files/pdf
Oznake:	Označite Brez oznak, prvi označite!

Podobne knjige/članki

Impact of Pre-Existing Chronic Viral Infection and Reactivation on the Development of Long COVID
od: Peluso, Michael J., et al.
Izdano: (2022)

Impact of Pre-Existing Chronic Viral Infection and Reactivation on the Development of Long COVID
od: Michael J. Peluso, et al.
Izdano: (2022)

Markers of Immune Activation and Inflammation in Individuals With Postacute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection
od: Michael J. Peluso, et al.
Izdano: (2021)

Plasma Markers of Neurologic Injury and Inflammation in People With Self-Reported Neurologic Postacute Sequelae of SARS-CoV-2 Infection
od: Michael J. Peluso, et al.
Izdano: (2022)

Markers of Immune Activation and Inflammation in Individuals With Postacute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection
od: Peluso, Michael J, et al.
Izdano: (2021)

Plasma Markers of Neurologic Injury and Inflammation in People With Self-Reported Neurologic Postacute Sequelae of SARS-CoV-2 Infection
od: Peluso, Michael J., et al.
Izdano: (2022)

Findings From Mayo Clinic’s Post-COVID Clinic: PASC Phenotypes Vary by Sex and Degree of IL-6 Elevation
od: Durstenfeld, Matthew S., et al.
Izdano: (2022)

Postacute sequelae and adaptive immune responses in people with HIV recovering from SARS-COV-2 infection
od: Michael J. Peluso, et al.
Izdano: (2022)

ROLE OF ANTIBODIES, INFLAMMATORY MARKERS, AND ECHOCARDIOGRAPHIC FINDINGS IN POST-ACUTE CARDIOPULMONARY SYMPTOMS AFTER SARS-COV-2 INFECTION
od: Durstenfeld, Matthew, et al.
Izdano: (2022)

Role of antibodies, inflammatory markers, and echocardiographic findings in postacute cardiopulmonary symptoms after SARS-CoV-2 infection
od: Durstenfeld, Matthew S., et al.
Izdano: (2022)

Role of antibodies, inflammatory markers, and echocardiographic findings in postacute cardiopulmonary symptoms after SARS-CoV-2 infection
od: Matthew S. Durstenfeld, et al.
Izdano: (2022)

Multimodal Molecular Imaging Reveals Tissue-Based T Cell Activation and Viral RNA Persistence for Up to 2 Years Following COVID-19
od: Michael J. Peluso, et al.
Izdano: (2023)

Effect of Oral Nirmatrelvir on Long COVID Symptoms: 4 Cases and Rationale for Systematic Studies
od: Peluso, Michael J., et al.
Izdano: (2022)

Effect of Oral Nirmatrelvir on Long COVID Symptoms: 4 Cases and Rationale for Systematic Studies
od: Michael J. Peluso, et al.
Izdano: (2022)

Tissue-based T cell activation and viral RNA persist for up to 2 years after SARS-CoV-2 infection
od: Michael J. Peluso, et al.
Izdano: (2024)

CE-541-04 CARDIAC ARRHYTHMIAS IN POST-ACUTE SEQUELAE OF SARS-COV-2 INFECTION ASSESSED BY AMBULATORY RHYTHM MONITORING
od: Hill, Christopher, et al.
Izdano: (2022)

Low Prevalence of Interferon α Autoantibodies in People Experiencing Symptoms of Post–Coronavirus Disease 2019 (COVID-19) Conditions, or Long COVID
od: Michael J. Peluso, et al.
Izdano: (2022)

Discordant Virus-Specific Antibody Levels, Antibody Neutralization Capacity, and T-cell Responses Following 3 Doses of SARS-CoV-2 Vaccination in a Patient With Connective Tissue Disease
od: Peluso, Michael J, et al.
Izdano: (2021)

Lack of Antinuclear Antibodies in Convalescent Coronavirus Disease 2019 Patients With Persistent Symptoms
od: Peluso, Michael J, et al.
Izdano: (2021)

An Unusual, Reversible Cause of Acute High-Output Heart Failure Complicated by Refractory Shock
od: Durstenfeld, Matthew S., et al.
Izdano: (2020)

Mechanisms and Primary Prevention of Atherosclerotic Cardiovascular Disease among People Living with HIV
od: Durstenfeld, Matthew S, et al.
Izdano: (2021)

HIV & SARS-CoV-2 biochemical interactions may not explain clinical outcomes among adults hospitalized with COVID-19 co-infected with HIV: Response to “Antagonism between hydrogen bonding and secondary chemical bonding to calcium in viruses”
od: DURSTENFELD, Matthew S., et al.
Izdano: (2022)

Long-Term SARS-CoV-2-Specific Immune and Inflammatory Responses Across a Clinically Diverse Cohort of Individuals Recovering from COVID-19
od: Peluso, Michael J., et al.
Izdano: (2021)

Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms
od: Peluso, Michael J., et al.
Izdano: (2021)

Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms
od: Michael J. Peluso, et al.
Izdano: (2021)

Reduced exercise capacity, chronotropic incompetence, and early systemic inflammation in cardiopulmonary phenotype Long COVID
od: Durstenfeld, Matthew S., et al.
Izdano: (2023)

Reduced Exercise Capacity, Chronotropic Incompetence, and Early Systemic Inflammation in Cardiopulmonary Phenotype Long Coronavirus Disease 2019
od: Matthew S. Durstenfeld, et al.
Izdano: (2023)

Cardiopulmonary exercise testing to evaluate post-acute sequelae of COVID-19 (“Long COVID”): a systematic review and meta-analysis
od: Durstenfeld, Matthew S., et al.
Izdano: (2022)

Use of Cardiopulmonary Exercise Testing to Evaluate Long COVID-19 Symptoms in Adults
od: Matthew S. Durstenfeld, et al.
Izdano: (2022)

Characterizing the COVID-19 illness experience to inform the study of post-acute sequelae and recovery: a qualitative study
od: Santiago-Rodriguez, Edda I., et al.
Izdano: (2021)

Characterizing the COVID-19 Illness Experience to Inform the Study of Post-acute Sequelae and Recovery
od: Santiago-Rodriguez, Edda I., et al.
Izdano: (2021)

Association of nirmatrelvir for acute SARS‐CoV‐2 infection with subsequent Long COVID symptoms in an observational cohort study
od: Matthew S. Durstenfeld, et al.
Izdano: (2024)

Persistence, Magnitude, and Patterns of Postacute Symptoms and Quality of Life Following Onset of SARS-CoV-2 Infection: Cohort Description and Approaches for Measurement
od: Michael J. Peluso, et al.
Izdano: (2021)

Rapid implementation of a cohort for the study of post-acute sequelae of SARS-CoV-2 infection/COVID-19
od: Michael J. Peluso, et al.
Izdano: (2021)

Plasma-based antigen persistence in the post-acute phase of COVID-19
od: Michael J. Peluso, et al.
Izdano: (2024)

Autoantigen profiling reveals a shared post-COVID signature in fully recovered and long COVID patients
od: Aaron Bodansky, et al.
Izdano: (2023)

Rapid implementation of a cohort for the study of post-acute sequelae of SARS-CoV-2 infection/COVID-19
od: Peluso, Michael J., et al.
Izdano: (2021)

Persistence, Magnitude, and Patterns of Postacute Symptoms and Quality of Life Following Onset of SARS-CoV-2 Infection: Cohort Description and Approaches for Measurement
od: Peluso, Michael J, et al.
Izdano: (2021)

LB8. Lower SARS-CoV-2 IgG and Pseudovirus Neutralization Titers Post-mRNA Vaccination among People Living with HIV
od: Spinelli, Matthew A, et al.
Izdano: (2021)

Outcomes of immunomodulatory and biologic therapy in people living with HIV: a report from two academic hospitals
od: PELUSO, Michael J., et al.
Izdano: (2020)